Literature DB >> 17186174

Clinical-pathological conference series from the Medical University of Graz : case no. 131: elevated transaminases in a 30-year-old male.

Csilla Putz-Bankuti1, Christian Datz, Winfried März, Carolin Lackner, Rudolf E Stauber, Michael Trauner, Hermann Toplak, Tatjana Stojakovic, Guenter J Krejs.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17186174     DOI： 10.1007/s00508-006-0718-7

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  9 in total

Review 1.  Familial hypobetalipoproteinemia: genetics and metabolism.

Authors:  G Schonfeld; X Lin; P Yue
Journal:  Cell Mol Life Sci       Date:  2005-06       Impact factor: 9.261

2.  Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.

Authors:  Elfriede Ruttmann; Larry J Brant; Hans Concin; Günter Diem; Kilian Rapp; Hanno Ulmer
Journal:  Circulation       Date:  2005-09-26       Impact factor: 29.690

3.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

Authors:  Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

4.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

Review 5.  Treatment strategies in nonalcoholic fatty liver disease.

Authors:  Herbert Tilg; Arthur Kaser
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-03

Review 6.  Review article: the treatment of fatty liver disease associated with the metabolic syndrome.

Authors:  G Marchesini; S Natale; R Manini; F Agostini
Journal:  Aliment Pharmacol Ther       Date:  2005-11       Impact factor: 8.171

7.  Long term prognosis of fatty liver: risk of chronic liver disease and death.

Authors:  S Dam-Larsen; M Franzmann; I B Andersen; P Christoffersen; L B Jensen; T I A Sørensen; U Becker; F Bendtsen
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

8.  Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.

Authors:  I J Hickman; J R Jonsson; J B Prins; S Ash; D M Purdie; A D Clouston; E E Powell
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

Review 9.  Familial hypobetalipoproteinemia: a review.

Authors:  Gustav Schonfeld
Journal:  J Lipid Res       Date:  2003-03-16       Impact factor: 5.922
  9 in total
  1 in total

Review 1.  [Congenital disorders of lipoprotein metabolism].

Authors:  W März; T B Grammer; G Delgado; M E Kleber
Journal:  Herz       Date:  2017-08       Impact factor: 1.443
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.